SIROASH 1 MG TABLETS are believed to contain Sirolimus 1mg; verify the composition on the product label.
Sirolimus belongs to the immunosuppressant class and acts as an mTOR inhibitor.
It reduces the activation and proliferation of certain immune cells.
This action can help suppress immune responses in selected clinical settings.
Treatment requires an individualized prescription and monitoring by a qualified specialist.
Use only according to the official product information and your healthcare professional's instructions.
MECHANISM OF ACTION:
Sirolimus binds to an intracellular protein called FKBP-12. The resulting complex inhibits mTOR, a protein involved in cell growth and proliferation.
This action reduces the proliferation of activated T lymphocytes and suppresses certain immune responses. These effects support its use in selected transplant-related and other specialist-managed conditions.
USAGE INSTRUCTIONS:
1. Confirm the active ingredient and strength on the manufacturer's packaging.
2. Take the medicine only under specialist medical supervision.
3. Follow the prescribed dose and schedule exactly.
4. Take it consistently according to your clinician's instructions regarding food and timing.
MEDICINAL ADVANTAGES:
- Suppresses selected immune responses.
- Helps prevent organ transplant rejection in approved treatment settings.
- Inhibits mTOR-related cell growth and proliferation.
- Provides an immunosuppressive treatment option for specific specialist-managed conditions.
OFF-LABEL USES:
Sirolimus may be considered for certain conditions outside its approved indications by specialists when supported by clinical evidence and an individualized risk-benefit assessment. Such use should not be promoted as routine treatment and must be directed by a qualified healthcare professional.
EXPERT ADVICE:
- Use only with a valid prescription and specialist oversight.
- Attend all recommended laboratory tests and follow-up appointments.
- Inform your clinician about infections, planned surgery, or slow-healing wounds.
- Discuss vaccinations with your healthcare professional; live vaccines may be unsuitable during immunosuppressive treatment.
- Do not share this medicine with another person.
- Seek prompt medical attention for signs of a serious infection or an unusual or severe reaction.
PRECAUTIONS:
Infection Risk:
Sirolimus suppresses immune function and can increase susceptibility to infections. Contact your healthcare professional if you develop signs of infection.
Liver and Kidney Function:
Tell your clinician about any liver or kidney condition. Monitoring requirements depend on your treatment and overall health.
Pregnancy and Breastfeeding:
Discuss pregnancy, plans to conceive, or breastfeeding with your specialist before treatment. Sirolimus may cause harm to a developing fetus.
Wound Healing and Surgery:
Sirolimus can impair wound healing. Inform your clinician before planned surgery or if you have a wound that is not healing properly.
Monitoring:
Regular medical assessments and laboratory monitoring may be necessary during treatment.
STORAGE INSTRUCTIONS:
- Store according to the manufacturer's instructions on the packaging.
- Keep the tablets in their original packaging.
- Protect from moisture and excessive heat.
- Keep out of reach of children.
- Do not use after the expiry date.
FREQUENTLY ASKED QUESTIONS:
Q: What is SIROASH 1 MG TABLETS?
A: The product name may refer to a 1mg Sirolimus tablet, but the active ingredient must be confirmed on the manufacturer's packaging.
Q: What is Sirolimus?
A: Sirolimus is an immunosuppressant that inhibits the mTOR pathway and reduces the activity of certain immune cells.
Q: How does Sirolimus work?
A: It binds to FKBP-12 and inhibits mTOR, reducing the proliferation of activated immune cells.
